Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205K Buy
+3,488
New +$146K ﹤0.01% 730
2021
Q4
Sell
-7,200
Closed -$334K 788
2021
Q3
$334K Hold
7,200
0.01% 500
2021
Q2
$288K Buy
+7,200
New +$308K 0.01% 549

Other funds holding VCYT

Bailard's VCYT Position: Q2 2026 in Review

Bailard opened a new position in Veracyte (VCYT) in Q2 2026: 3,488 shares worth $205K. The stake represents ﹤0.01% of the portfolio and ranks #730 among its holdings. This is a return to the name: Bailard previously reported a position in VCYT as recently as Q3 2021.

Bailard first reported a position in VCYT in Q2 2021 and has held it in 3 quarters since. The position peaked at $334K in Q3 2021. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Bailard held 3,488 shares of Veracyte worth $205K as of Q2 2026.
  • Veracyte was a new Bailard position in Q2 2026.
  • Veracyte made up ﹤0.01% of Bailard's portfolio in Q2 2026, its #730 holding.
  • Bailard first reported a position in Veracyte in Q2 2021 and has held it in 3 quarters since.
  • Bailard's Veracyte position peaked at $334K in Q3 2021.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.